Ultralife (NASDAQ:ULBI) reported quarterly earnings of $0.13 per share which missed the analyst consensus estimate of $0.15 by 13.33 percent. This is a 38.1 percent decrease over earnings of $0.21 per share from the same period last year. The company reported quarterly sales of $50.75 million which beat the analyst consensus estimate of $48.00 million by 5.72 percent. This is a 21.03 percent increase over sales of $41.93 million the same period last year.